Ctc Capital Management, LLC Selecta Biosciences Inc Transaction History
Ctc Capital Management, LLC
- $47.2 Million
- Q1 2023
A detailed history of Ctc Capital Management, LLC transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Ctc Capital Management, LLC holds 11,300 shares of SELB stock, worth $9,492. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,300Holding current value
$9,492% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding SELB
# of Institutions
68Shares Held
41.4MCall Options Held
16.8KPut Options Held
0-
Artal Group S.A. Luxembourg, N49.14MShares$7.67 Million0.41% of portfolio
-
Black Rock Inc. New York, NY7.25MShares$6.09 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.32MShares$5.3 Million0.0% of portfolio
-
Nano Dimension, Inc.3.79MShares$3.18 Million25.2% of portfolio
-
Geode Capital Management, LLC Boston, MA2.5MShares$2.1 Million0.0% of portfolio
About SELECTA BIOSCIENCES INC
- Ticker SELB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 152,712,992
- Market Cap $128M
- Description
- Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...